Beta Bionics has raised $57.5 million from 24 investors to help fund the development of its iLet bionic pancreas, according to a document filed with the SEC this week.
The Mass.-based company is offering equity and securities as part of the indefinite round.
Get the full story at our sister site, Drug Delivery Business News.
